Safe nanoengineering and incorporation of transplant populations in a neurosurgical grade biomaterial, DuraGen PlusTM, for protected cell therapy applications. (2020)
Attributed to:
Regenerative Medicine Concept Innovation Fund
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2020.02.028
PubMed Identifier: 32087299
Publication URI: http://europepmc.org/abstract/MED/32087299
Type: Journal Article/Review
Volume: 321
Parent Publication: Journal of controlled release : official journal of the Controlled Release Society
ISSN: 0168-3659